Real-time enrollment status for this diabetic retinopathy clinical trial
Current Status
Recruiting
Checked: October 20, 2026 at 4:53 AM UTC
| NCT Number | NCT07705555 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Retinopathy |
| Phase | PHASE3 |
| Target Enrollment | 960 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 9, 2026 (1 week ago) |
As of October 20, 2026: Clinical trial NCT07705555 is currently recruiting participants. This phase3 study for diabetic retinopathy is actively seeking new participants at 21 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07705555 is actively recruiting participants as of October 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07705555 was last updated 1 week ago (October 9, 2026). HelloStudys verifies this status automatically.